Pfizer Exubera Has Mid-Year Launch Trigger, Heavy Dose Of Instructions
Marketing of Pfizer's inhaled insulin Exubera for treatment of adult diabetes mellitus is expected to begin by the end of August
Marketing of Pfizer's inhaled insulin Exubera for treatment of adult diabetes mellitus is expected to begin by the end of August